Abstract
Research has long assumed that boards of directors use their human capital to monitor strategy or advise on it, but less is known about how directors share and extend their varying expertise in order to become involved. In this study, we address this issue by studying board involvement in product innovation - a major, long-term strategic challenge. Using a multiple-case study of three listed pharmaceutical firms, we find that a multi-channel board design facilitates two board involvement processes. First, the specialized director and the board subgroup channels monitor scientific issues and advise on them through dynamic knowledge sharing exchanges with employees at multiple levels. Second, the full board channel reacts to innovation proposals in formal board meetings and focuses on the strategic aspects of innovation when monitoring and advising. Outside directors’ specialized knowledge and the full board’s diverse human capital are jointly leveraged for innovation through these processes. Our findings contribute to corporate governance research by providing a systematic and fine-grained framework that conceptualizes governance as a multi-channel and multi-process approach and depicts the microdynamics of board involvement.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.